Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News VALEANT PHARMACEUTICALS INTL INC T.VRX

Healthcare Drug Manufacturers - Specialty & Generic
"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."

Recent & Breaking News (TSX:VRX)

Watch These 10 Huge Call Purchases In Wednesday Trade

Benzinga.com  October 4, 2017

Bausch + Lomb Introduces Biotrue® ONEday for Astigmatism Contact Lenses in Europe

PR Newswire October 3, 2017

Valeant Will Release Third-Quarter 2017 Financial Results On November 7

PR Newswire October 3, 2017

Valeant Announces Pricing Of Private Offering Of Senior Secured Notes

PR Newswire October 2, 2017

Valeant And One Of Its Subsidiaries Commence Cash Tender Offers For Up To $1,000,000,000 Outstanding Principal Amount

PR Newswire October 2, 2017

Valeant Announces Launch Of Private Offering Of Senior Secured Notes

PR Newswire October 2, 2017

Valeant Pharmaceuticals Completes Sale Of iNova Pharmaceuticals To Pacific Equity Partners And The Carlyle Group

PR Newswire September 29, 2017

Watch These 10 Huge Put Purchases In Thursday Trade

Benzinga.com  September 28, 2017

Valeant Pharmaceuticals Provides Update On Canadian Regulatory Filing About Future Financing Plans

PR Newswire September 27, 2017

Valeant to Participate at the Deutsche Bank 25th Annual Leveraged Finance Conference

PR Newswire September 27, 2017

Watch These 8 Huge Put Purchases In Tuesday Trade

Benzinga.com  September 19, 2017

What You Should Know About The Drug Approval Valeant Could Receive This Week

Benzinga.com  September 18, 2017

Valeant To Participate At The Cantor Fitzgerald Global Healthcare Conference

PR Newswire September 18, 2017

Valeant Commits $200,000 to Support Hurricane Relief Efforts

PR Newswire September 15, 2017

Watch These 7 Huge Put Purchases In Wednesday Trade

Benzinga.com  September 13, 2017

Valeant To Participate At The Morgan Stanley Global Healthcare Conference

PR Newswire September 6, 2017

Ortho Dermatologics Submits New Drug Application To The U.S. Food And Drug Administration For Psoriasis Treatment IDP-118

PR Newswire September 5, 2017

Technical Snapshots for these Drug Delivery Stocks -- Delcath Systems, Valeant Pharma, PetMed Express, and Adamis Pharma

PR Newswire September 1, 2017

Watch These 8 Huge Call Purchases In Wednesday Trade

Benzinga.com  August 30, 2017

There's No Fundamental Reason For Valeant Shares To Be Down

Benzinga.com  August 29, 2017